Mayo Clinic discovery in bone marrow cancer points to potential drug targets
New research from Mayo Clinic’s Center for Individualized Medicine finds that patients with ASXL1-mutant chronic myelomonocytic leukemia — an uncommon type of cancer of the bone marrow —… read more.
